Logo image of OWLT

OWLET INC (OWLT) Stock Fundamental Analysis

NYSE:OWLT - New York Stock Exchange, Inc. - US69120X2062 - Common Stock - Currency: USD

5.22  +0.26 (+5.24%)

After market: 5.27 +0.05 (+0.96%)

Fundamental Rating

2

OWLT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. OWLT may be in some trouble as it scores bad on both profitability and health. OWLT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year OWLT has reported negative net income.
OWLT had a negative operating cash flow in the past year.
In the past 5 years OWLT always reported negative net income.
In the past 5 years OWLT always reported negative operating cash flow.
OWLT Yearly Net Income VS EBIT VS OCF VS FCFOWLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of OWLT (-24.60%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -24.6%
ROE N/A
ROIC N/A
ROA(3y)-90.91%
ROA(5y)-72.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OWLT Yearly ROA, ROE, ROICOWLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 500 1K 1.5K

1.3 Margins

OWLT has a Gross Margin (47.97%) which is in line with its industry peers.
OWLT's Gross Margin has declined in the last couple of years.
OWLT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
OWLT Yearly Profit, Operating, Gross MarginsOWLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

OWLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OWLT has more shares outstanding
The debt/assets ratio for OWLT is higher compared to a year ago.
OWLT Yearly Shares OutstandingOWLT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M 8M
OWLT Yearly Total Debt VS Total AssetsOWLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -4.99, we must say that OWLT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -4.99, OWLT is doing worse than 69.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.99
ROIC/WACCN/A
WACC9.53%
OWLT Yearly LT Debt VS Equity VS FCFOWLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 20M -20M 40M -40M -60M -80M

2.3 Liquidity

A Current Ratio of 1.46 indicates that OWLT should not have too much problems paying its short term obligations.
OWLT has a worse Current ratio (1.46) than 78.19% of its industry peers.
A Quick Ratio of 1.17 indicates that OWLT should not have too much problems paying its short term obligations.
OWLT has a worse Quick ratio (1.17) than 69.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 1.17
OWLT Yearly Current Assets VS Current LiabilitesOWLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

OWLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 88.94%, which is quite impressive.
Looking at the last year, OWLT shows a very strong growth in Revenue. The Revenue has grown by 107.53%.
The Revenue for OWLT have been decreasing by -10.53% on average. This is quite bad
EPS 1Y (TTM)88.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.29%
Revenue 1Y (TTM)107.53%
Revenue growth 3Y-10.53%
Revenue growth 5YN/A
Sales Q2Q%140.22%

3.2 Future

OWLT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.75% yearly.
The Revenue is expected to grow by 27.17% on average over the next years. This is a very strong growth
EPS Next Y66.14%
EPS Next 2Y26.82%
EPS Next 3Y19.59%
EPS Next 5Y15.75%
Revenue Next Year37.4%
Revenue Next 2Y28.45%
Revenue Next 3Y26.19%
Revenue Next 5Y27.17%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OWLT Yearly Revenue VS EstimatesOWLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
OWLT Yearly EPS VS EstimatesOWLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OWLT. In the last year negative earnings were reported.
Also next year OWLT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OWLT Price Earnings VS Forward Price EarningsOWLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OWLT Per share dataOWLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as OWLT's earnings are expected to grow with 19.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.82%
EPS Next 3Y19.59%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OWLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OWLET INC

NYSE:OWLT (2/21/2025, 8:04:01 PM)

After market: 5.27 +0.05 (+0.96%)

5.22

+0.26 (+5.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)03-05 2025-03-05/amc
Inst Owners49.17%
Inst Owner Change-2.18%
Ins Owners8.34%
Ins Owner Change18.93%
Market Cap83.73M
Analysts82.86
Price Target15.3 (193.1%)
Short Float %2.54%
Short Ratio9.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)106.13%
Min EPS beat(2)100%
Max EPS beat(2)112.26%
EPS beat(4)2
Avg EPS beat(4)-38.74%
Min EPS beat(4)-194.12%
Max EPS beat(4)112.26%
EPS beat(8)4
Avg EPS beat(8)-33.46%
EPS beat(12)5
Avg EPS beat(12)-29.67%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.03%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)9.59%
Revenue beat(4)1
Avg Revenue beat(4)-2.16%
Min Revenue beat(4)-11.99%
Max Revenue beat(4)9.59%
Revenue beat(8)1
Avg Revenue beat(8)-9.65%
Revenue beat(12)1
Avg Revenue beat(12)-18.51%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)27.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.9
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)-0.98
Fwd EYN/A
FCF(TTM)-1.05
FCFYN/A
OCF(TTM)-1
OCFYN/A
SpS5.82
BVpS-0.59
TBVpS-0.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.97%
FCFM N/A
ROA(3y)-90.91%
ROA(5y)-72.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
F-Score4
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 162.55%
Cap/Sales 0.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.46
Quick Ratio 1.17
Altman-Z -4.99
F-Score4
WACC9.53%
ROIC/WACCN/A
Cap/Depr(3y)98.78%
Cap/Depr(5y)156.23%
Cap/Sales(3y)1.68%
Cap/Sales(5y)2.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.29%
EPS Next Y66.14%
EPS Next 2Y26.82%
EPS Next 3Y19.59%
EPS Next 5Y15.75%
Revenue 1Y (TTM)107.53%
Revenue growth 3Y-10.53%
Revenue growth 5YN/A
Sales Q2Q%140.22%
Revenue Next Year37.4%
Revenue Next 2Y28.45%
Revenue Next 3Y26.19%
Revenue Next 5Y27.17%
EBIT growth 1Y53.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year82.67%
EBIT Next 3Y29.05%
EBIT Next 5Y21.77%
FCF growth 1Y78.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y79.2%
OCF growth 3YN/A
OCF growth 5YN/A